FIT Test for Colorectal Cancer Screening : Detection Rate and Risk Factors of Colorectal Cancer in Amnatcharoen Hospital
Main Article Content
Abstract
Objective: To study detection rate and identify risk factors associated with colorectal cancer in patients who had positive results from FIT test screening and colonoscopy in Amnatcharoen Hospital.
Methods: This is a retrospective cohort study. Medical records of patients who had positive results from FIT test screening and colonoscopy in Amnatcharoen Hospital from 1 December 2021 to 30 November 2022 were reviewed. Patients’ characteristics including age, gender, weight, height, underlying disease, sign and symptoms, smoking, alcohol consumption, family history, Hb level and CEA level were collected. Results after colonoscopy including pathological results were collected. Data were collected and analysed with Chi-square test, Binary Logistic regression analysis and multiple logistic regression reported with Adjusted Odds ratio and 95%CI.
Results: This study includes 193 pateints who had positive results from FIT test screening and colonoscopy in Amnatcharoen Hospital from 1 December 2021 to 30 November 2022 in Amnatcharoen Hospital. Colonoscopy detected colorectal polyp in 51 cases (26.42%). Pathological report revealed 47 (92.16%) benign and 4 (7.84%) malignant colorectal polyp. Among all cases that were screened for colorectal cancer, the detection rate for malignancy was 2.07%. Risk factors associated to colorectal cancer in this study were dyslipidemia (aOR 17.54 (0.98-312.70), 95% CI 2.06-120.52, p-value 0.001) and chronic renal disease (aOR 16.99 (1.01-286.41), 95% CI 1.26-85.87, p-value 0.01).
Conclusion: Detection rate of colorectal cancer in patients who had positive results from FIT test screening and colonoscopy was 2.07%. Risk factors associated to colorectal cancer in this study included dyslipidemia and chronic renal disease.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของยโสธรเวชสาร
References
หน่วยงานเวชระเบียนและฐานข้อมูลโรคมะเร็ง สถาบันมะเร็งแห่งชาติ. ทะเบียนมะเร็งระดับโรงพยาบาล พ.ศ. 2563. กรุงเทพฯ: กลุ่มงานดิจิทัลการแพทย์; 2564.
Lieberman DA. Clinical practice. Screening for colorectal cancer. N Engl J Med 2009; 361(12): 1179–87. doi: 10.1056/NEJMcp0902176. PubMed PMID: 19759380.
Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2021; 325(19): 1978-98. doi: 10.1001/jama.2021.4417. PubMed PMID: 34003220.
Johnson DA, Barkun AN, Cohen LB, Dominitz JA, Kaltenbach T, Martel M, et al. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multisociety task force on colorectal cancer. Gastroenterology 2014; 147(4): 903-24. doi: 10.1053/j.gastro.2014.07.002. PubMed PMID: 25239068.
Riemann JF, Schröder C, Kallenbach M, Giersiepen K, Schmoll HJ. Benefits and Risks of Colorectal Cancer Screening. Oncol Res Treat 2014; 37 Suppl 3, 11–20. doi: 10.1159/000364886. PubMed PMID: 25195828.
Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ, et al. Colorectal Cancer Screening for Average-Risk Adults: 2018 Guideline Update From the American Cancer Society. CA Cancer J Clin 2018; 68(4): 250–81. doi: 10.3322/caac.21457. PubMed PMID: 29846947.
Levin TR, Corley DA, Jensen CD, Schottinger JE, Quinn VP, Zauber AG, et al. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. Gastroenterology 2018; 155(5): 1383–91. doi: 10.1053/j.gastro.2018.07.017. PubMed PMID: 30031768.
Elfant AB. Hot Topics in Primary Care: Colorectal Cancer Screening. J Fam Pract 2015; 64(12 Suppl):S10–5. PubMed PMID: 26845007.
Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and surveillance for early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US MultiSociety Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58(3): 130-60. doi: 10.3322/CA.2007.0018. PubMed PMID: 18322143.
U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149(9): 62737. doi: 10.7326/0003-4819-149-9-200811040-00243. PubMed PMID: 18838716.
Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 149(9): 63858. doi: 10.7326/0003-4819-149-9-200811040-00245. PubMed PMID: 18838718.
Hannan LM, Jacobs EJ, Thun MJ. The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the United States. Cancer Epidemiol Biomarkers Prev 2009; 18(12): 3362-7. doi: 10.1158/1055-9965.EPI-09-0661. PubMed PMID: 19959683.
LoConte NK, Brewster AM, Kaur JS, Merrill JK, Alberg AJ. Alcohol and cancer: A statement of the American Society of Clinical Oncology. J Clin Oncol 2018; 36(1): 83-93. doi: 10.1200/JCO.2017.76.1155. PubMed PMID: 29112463.
Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007; 2007(1): CD001216. doi: 10.1002/14651858.
CD001216.pub2. PubMed PMID: 17253456.
Reumkens A, Rondagh EJ, Bakker CM, Winkens B, Masclee AA, Sanduleanu S. Post-colonoscopy complications: A systematic review, time trends, and meta-analysis of population based studies. Am J Gastroenterol 2016; 111(8): 1092–101. doi: 10.1038/ajg.2016.234. PubMed PMID: 27296945.
Pickhardt PJ, Hasan C, Halligan S, Marmo R. Colorectal cancer: CT colonography and colonoscopy for detection--systematic review and meta-analysis. Radiology 2011: 259(2): 393-405.
doi: 10.1148/radiol.11101887. PubMed PMID: 21415247.
Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2006; 107(9): 2152-9. doi: 10.1002/cncr.22230. PubMed PMID: 16998938.
World Cancer Research Fund/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Cancer: a global perspective. Continuous Update Project Expert Report 2018; 2018.
Kohler LN, Harris RB, Oren E, Roe DJ, Lance P, Jacobs ET. Adherence to nutrition and physical activity cancer prevention guidelines and development of colorectal adenoma. Nutrients 2018; 10(8): 1098.
doi: 10.3390/nu10081098. PubMed PMID: 30115827.
Wu MY, Chang TC, Chao TY, Huang MT, Lin HW. Risk of colorectal cancer in chronic kidney disease: a matched cohort study based on administrative data. Ann Surg Oncol 2013; 20(12): 3885-91.
doi: 10.1245/s10434-013-3065-8. PubMed PMID: 23807660.